Tiny heart device could patch leaky valve without surgery
NCT ID NCT07385625
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This trial tests a device called 'Pivot Bridge' for people with a severe leaky heart valve (tricuspid regurgitation). The device is inserted through a leg vein and sits in the valve to help it close better. It is only used for about a week. The study involves 20 adults who have already tried medication. The goal is to see if the device safely reduces the leak and improves symptoms.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Pivot Bridge device
- What this could lead to
- If successful, this device could provide a temporary, less invasive way to reduce severe tricuspid regurgitation and improve symptoms without open-heart surgery.
- What could go wrong
- This is a very early, small trial with only 20 participants and no control group. The device is temporary and risks include complications from catheter insertion or device failure.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRICUSPID REGURGITATION FUNCTIONAL are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Asan Medical Center
RECRUITINGSeoul, Songpa-gu, 05505, South Korea
-
Keimyung University Dongsan Hospital
RECRUITINGDaegu, Dalseo-gu, 42601, South Korea
-
Pusan National University Yangsan Hospital
RECRUITINGYangsan, Gyeongsangnam-do, 50602, South Korea
-
Yonsei University Health System, Severance Hospital
RECRUITINGSeoul, Seodaemun-gu, 03722, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.